BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22916741)

  • 1. Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort.
    Teras LR; Patel AV; Hildebrand JS; Gapstur SM
    Leuk Lymphoma; 2013 Apr; 54(4):720-5. PubMed ID: 22916741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
    Hildebrand JS; Gapstur SM; Feigelson HS; Teras LR; Thun MJ; Patel AV
    Int J Cancer; 2010 Dec; 127(12):2928-35. PubMed ID: 21351271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of postmenopausal hormone use and ovarian cancer risk.
    Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
    Br J Cancer; 2007 Jan; 96(1):151-6. PubMed ID: 17179984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study.
    Diver WR; Patel AV; Thun MJ; Teras LR; Gapstur SM
    Cancer Causes Control; 2012 Aug; 23(8):1231-40. PubMed ID: 22689321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of non-hodgkin lymphoma.
    Teras LR; Gapstur SM; Patel AV; Thun MJ; Diver WR; Zhai Y; Jacobs EJ
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):422-8. PubMed ID: 23329726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.
    Lu Y; Wang SS; Sullivan-Halley J; Chang ET; Clarke CA; Henderson KD; Ma H; Duan L; Lacey JV; Deapen D; Bernstein L
    Int J Cancer; 2011 Aug; 129(4):974-82. PubMed ID: 20957632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.
    Mildon KH; Ansell P; Roman E; Kane EV
    Cancer Causes Control; 2010 Dec; 21(12):2079-83. PubMed ID: 20697798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to environmental tobacco smoke and risk of non-Hodgkin lymphoma in nonsmoking men and women.
    Diver WR; Teras LR; Gaudet MM; Gapstur SM
    Am J Epidemiol; 2014 Apr; 179(8):987-95. PubMed ID: 24569639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.
    Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS
    Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol intake and the incidence of non-hodgkin lymphoid neoplasms in the cancer prevention study II nutrition cohort.
    Gapstur SM; Diver WR; McCullough ML; Teras LR; Thun MJ; Patel AV
    Am J Epidemiol; 2012 Jul; 176(1):60-9. PubMed ID: 22562662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
    Wang Z; Phillips LS; Rohan TE; Ho GYF; Shadyab AH; Bidulescu A; Rudick CN; Pan K; Chen Z; Luo J
    Int J Cancer; 2023 Apr; 152(8):1556-1569. PubMed ID: 36444502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors and non-Hodgkin lymphoma: a systematic review.
    Costas L; de Sanjosé S; Infante-Rivard C
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):181-93. PubMed ID: 25132165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
    Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
    Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Troy JD; Hartge P; Weissfeld JL; Oken MM; Colditz GA; Mechanic LE; Morton LM
    Am J Epidemiol; 2010 Jun; 171(12):1270-81. PubMed ID: 20494998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.